Charles W Newhall III

Companies

S Supernus Pharmaceuticals, Inc.Director −$1.3M

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.